These findings suggest that LINC01194 regulates the proliferation and migration of HCC cells via the miR-655-3p/SMAD5 axis, providing a promising and novel biomarker for diagnosing and treating HCC. The gene discussed is LINC01194; the disease is hepatocellular carcinoma.